Alkem Lab

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE540L01014
  • NSEID: ALKEM
  • BSEID: 539523
INR
5,686.95
75.3 (1.34%)
BSENSE

Dec 05

BSE+NSE Vol: 37.74 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
12,964.52
12,667.58
11,599.26
10,634.19
8,865.01
8,344.36
7,357.19
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
12,964.52
12,667.58
11,599.26
10,634.19
8,865.01
8,344.36
7,357.19
Raw Material Cost
3,440.37
3,294.59
3,056.92
3,226.06
2,394.54
2,131.83
1,811.14
Purchase of Finished goods
1,514.02
1,628.87
1,387.55
1,489.71
1,437.76
1,443.06
1,130.19
(Increase) / Decrease In Stocks
-190.13
14.12
462.37
-535.48
-333.84
-229.95
3.64
Employee Cost
2,453.92
2,201.01
2,131.35
1,962.71
1,621.03
1,505.49
1,362.46
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
3,234.19
3,283.50
2,951.62
2,438.27
1,803.13
2,020.54
1,934.99
Total Expenditure (Excl Depreciation)
10,452.37
10,422.09
9,989.81
8,581.27
6,922.62
6,870.97
6,242.42
Operating Profit (PBDIT) excl Other Income
2,512.15
2,245.49
1,609.45
2,052.92
1,942.39
1,473.39
1,114.77
Other Income
493.74
310.84
216.08
162.65
233.21
104.22
87.70
Operating Profit (PBDIT)
3,005.89
2,556.33
1,825.53
2,215.57
2,175.60
1,577.61
1,202.47
Interest
121.70
112.41
107.36
52.37
58.92
65.06
54.63
Exceptional Items
0.00
-121.49
-102.98
-14.96
0.00
0.00
0.00
Gross Profit (PBDT)
2,884.19
2,322.43
1,615.19
2,148.24
2,116.68
1,512.55
1,147.84
Depreciation
357.16
299.30
310.42
303.96
274.58
252.76
193.18
Profit Before Tax
2,527.03
2,023.13
1,304.77
1,844.28
1,842.10
1,259.79
954.66
Tax
311.03
211.67
297.96
163.96
224.33
110.48
181.02
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,216.00
1,811.46
1,006.81
1,680.32
1,617.77
1,149.31
773.64
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,216.00
1,811.46
1,006.81
1,680.32
1,617.77
1,149.31
773.64
Share in Profit of Associates
-0.62
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-49.90
-15.69
-22.64
-34.70
-32.75
-22.24
-13.13
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,165.48
1,795.77
984.17
1,645.62
1,585.02
1,127.07
760.51
Equity Capital
23.91
23.91
23.91
23.91
23.91
23.91
23.91
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
11,960.96
10,288.15
9,021.38
8,613.99
7,352.82
6,136.76
5,415.43
Earnings per share (EPS)
181.14
150.21
82.32
137.65
132.58
94.28
63.61
Diluted Earnings per share
181.11
150.19
82.31
137.63
132.57
94.26
63.61
Operating Profit Margin (Excl OI)
19.38%
17.73%
13.88%
19.3%
21.91%
17.66%
15.15%
Gross Profit Margin
22.25%
18.33%
13.92%
20.2%
23.88%
18.13%
15.6%
PAT Margin
17.09%
14.3%
8.68%
15.8%
18.25%
13.77%
10.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 2.34% vs 9.21% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 20.59% vs 82.47% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 11.88% vs 39.52% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 8.26% vs 4.70% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Alkem Lab With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
12,964.52
31,723.73
-18,759.21
-59.13%
Other Operating Income
0.00
0.00
0.00
Total Operating income
12,964.52
31,723.73
-18,759.21
-59.13%
Raw Material Cost
3,440.37
10,736.76
-7,296.39
-67.96%
Purchase of Finished goods
1,514.02
2,887.11
-1,373.09
-47.56%
(Increase) / Decrease In Stocks
-190.13
-597.63
407.50
68.19%
Employee Cost
2,453.92
4,475.62
-2,021.70
-45.17%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
3,234.19
7,639.08
-4,404.89
-57.66%
Total Expenditure (Excl Depreciation)
10,452.37
25,140.94
-14,688.57
-58.42%
Operating Profit (PBDIT) excl Other Income
2,512.15
6,582.79
-4,070.64
-61.84%
Other Income
493.74
621.85
-128.11
-20.60%
Operating Profit (PBDIT)
3,005.89
7,204.64
-4,198.75
-58.28%
Interest
121.70
457.24
-335.54
-73.38%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
2,884.19
6,747.40
-3,863.21
-57.25%
Depreciation
357.16
1,649.42
-1,292.26
-78.35%
Profit Before Tax
2,527.03
5,097.98
-2,570.95
-50.43%
Tax
311.03
1,582.72
-1,271.69
-80.35%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
2,216.00
3,515.26
-1,299.26
-36.96%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
2,216.00
3,515.26
-1,299.26
-36.96%
Share in Profit of Associates
-0.62
-31.69
31.07
98.04%
Minority Interest
-49.90
2.31
-52.21
-2,260.17%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,165.48
3,485.88
-1,320.40
-37.88%
Equity Capital
23.91
58.08
-34.17
-58.83%
Face Value
2.00
1.00
0.00
Reserves
11,960.96
32,595.24
-20,634.28
-63.30%
Earnings per share (EPS)
181.14
60.02
121.12
201.80%
Diluted Earnings per share
181.11
59.81
121.30
202.81%
Operating Profit Margin (Excl OI)
19.38%
20.98%
0.00
-1.60%
Gross Profit Margin
22.25%
21.50%
0.00
0.75%
PAT Margin
17.09%
11.10%
0.00
5.99%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 12,964.52 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.34% vs 9.21% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 2,165.48 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 20.59% vs 82.47% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,512.15 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 11.88% vs 39.52% in Mar 2024

Annual - Interest
Interest 121.70 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 8.26% vs 4.70% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.38%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024